RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
   West Nile Virus
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Virology Channel

subscribe to Virology newsletter
Latest Research : Microbiology : Virology

   EMAIL   |   PRINT
Epstein-Barr Virus Found in Breast Cancer Tissue May Impact Efficiency of Treatment

Jan 20, 2006 - 2:01:00 PM , Reviewed by: Priya Saxena
"Consequently, even if a small number of breast cancer cells are EBV infected, the impact of EBV infection on the efficiency of anticancer treatment might be of importance,"

[RxPG] Epstein-Barr virus has been detected in breast cancer tissue and tumor cells and may impact the efficiency of chemotherapeutic drug treatment say researchers from France and Japan. They report their findings in the January 2006 issue of the Journal of Virology.

A ubiquitous human herpesvirus, the Epstein-Barr virus (EBV), has been previously linked to skin and gastric cancer, as well as cancer of the salivary glands and thymus. New studies have detected EBV in breast cancer specimens and have prompted researchers to examine the effect of infection with EBV on anticancer drug treatment.

In the study biopsy specimens of breast cancer tissue and tumor cells were tested for the EBV genome. The genome was identified in about half of the specimens, however the viral load was highly variable from tumor to tumor. These findings indicate that although EBV isn't likely to cause breast cancer, it may contribute to tumor progression. In addition, researchers studied the EBV infected cells in vitro and found that the virus may contribute to the resistance of paclitaxel (taxol), chemotherapy commonly used in the treatment breast cancer, and cause overexpression of the multidrug resistance gene (MDRI).

"Consequently, even if a small number of breast cancer cells are EBV infected, the impact of EBV infection on the efficiency of anticancer treatment might be of importance," say the researchers.

Publication: H. Arbach, V. Viglasky, F. Lefeu, J.M. Guinebretiere, V. Ramirez, N. Bride, N. Boualaga, T. Bauchet, J.P. Peyrat, M.C. Mathieu, S. Mourah, M.P. Podgorniak, J.M. Seignerin, K. Takada, I. Joab. 2006. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). Journal of Virology, 80. 2: 845-853.
On the web: www.asm.org 

Advertise in this space for $10 per month. Contact us today.

Related Virology News
How West Nile virus evades immune defenses
Innovative method for creating a human cytomegalovirus vaccine outlined
Cracking Virus Protection Shield
Viruses trade-off between survival and reproduction
New hybrid virus provides targeted molecular imaging of cancer
Mass spectrometry to detect norovirus particles
xCT molecule is a major gateway for KSHV to enter human cells
Surprising discovery about the inner workings of vesicular stomatitis virus (VSV)
New human retrovirus - Xenotropic MuLV-related virus (XMRV)
Viruses can be forced to evolve as better delivery vehicles for gene therapy

Subscribe to Virology Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)